Ensuring Sufficient Manufacturing Capacity for COVID-19 Therapeutics

Ensuring Sufficient Manufacturing Capacity for COVID-19 Therapeutics

KEI Roundtable on Pathways to Scale Up Manufacturing Capacity for COVID-19 VaccinesПодробнее

KEI Roundtable on Pathways to Scale Up Manufacturing Capacity for COVID-19 Vaccines

UCL VaxHub Vaccine manufacturing during a global pandemic: what have we learnt from COVID-19?Подробнее

UCL VaxHub Vaccine manufacturing during a global pandemic: what have we learnt from COVID-19?

Session 4 of the COVID-19 Vaccine Supply Chain and Regulatory Transparency Technical SymposiumПодробнее

Session 4 of the COVID-19 Vaccine Supply Chain and Regulatory Transparency Technical Symposium

Advance the Manufacturing of COVID-19 Vaccines and other Health TechonologiesПодробнее

Advance the Manufacturing of COVID-19 Vaccines and other Health Techonologies

'We need more manufacturing capacity' for Covid vaccines, expert saysПодробнее

'We need more manufacturing capacity' for Covid vaccines, expert says

Regional Platform to Advance the Manufacturing of COVID-19 Vaccines in the Americas - ENGLISH AUDIOПодробнее

Regional Platform to Advance the Manufacturing of COVID-19 Vaccines in the Americas - ENGLISH AUDIO

GMP Manufacturing of Messenger RNA Therapeutics and Vaccines: Case Study of a SA SARS CoV-2 VaccineПодробнее

GMP Manufacturing of Messenger RNA Therapeutics and Vaccines: Case Study of a SA SARS CoV-2 Vaccine

Session 2: UKVN Vaccine Manufacturing Research Hubs role in global manufacturing capacity buildingПодробнее

Session 2: UKVN Vaccine Manufacturing Research Hubs role in global manufacturing capacity building

Canada investing in COVID-19 vaccine manufacturingПодробнее

Canada investing in COVID-19 vaccine manufacturing

Biotech, Developing & Developed Countries Vaccine Manufacturers COVID-19 Press Briefing - 16 Dec 21Подробнее

Biotech, Developing & Developed Countries Vaccine Manufacturers COVID-19 Press Briefing - 16 Dec 21

How Can We Ensure Equitable Access to the COVID-19 Vaccine?Подробнее

How Can We Ensure Equitable Access to the COVID-19 Vaccine?

Bloomberg Prognosis:How Covid-19 is Reshaping the Global Healthcare EcosystemПодробнее

Bloomberg Prognosis:How Covid-19 is Reshaping the Global Healthcare Ecosystem

Session 2 of the COVID-19 Vaccine Supply Chain and Regulatory Transparency Technical Symposium)Подробнее

Session 2 of the COVID-19 Vaccine Supply Chain and Regulatory Transparency Technical Symposium)

Delivering therapeutic mAbs for COVID-19: What can be done in just one year?Подробнее

Delivering therapeutic mAbs for COVID-19: What can be done in just one year?

Aspen hosts webinar on expansion of Africa's COVID-19 vaccine manufacturing capacityПодробнее

Aspen hosts webinar on expansion of Africa's COVID-19 vaccine manufacturing capacity

Covid-19 Vaccine Production, Global Equity and Open SourceПодробнее

Covid-19 Vaccine Production, Global Equity and Open Source

Will COVID-19 Impact the Speed of Patient Innovation in the Long-Term?Подробнее

Will COVID-19 Impact the Speed of Patient Innovation in the Long-Term?

Regional Platform to Advance the Manufacturing of COVID-19 - ORIGINAL AUDIOПодробнее

Regional Platform to Advance the Manufacturing of COVID-19 - ORIGINAL AUDIO

ACT-A THERAPEUTICS PARTNERSHIP MANUFACTURER WEBINARПодробнее

ACT-A THERAPEUTICS PARTNERSHIP MANUFACTURER WEBINAR